Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market
Holding AU:IXC?
Track your performance easily

Invex Therapeutics Ltd. (IXC) Financial Statements

3 Followers

Invex Therapeutics Ltd. Financial Overview

Invex Therapeutics Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.021; its P/E ratio is -4.13; Invex Therapeutics Ltd. is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20
Income Statement-
Total Revenue---
Gross Profit---
EBIT---
EBITDA---
Net Income Common Stockholders---
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 29.34MAU$ 32.72MAU$ 26.30M
Total AssetsAU$ 29.49MAU$ 32.74MAU$ 26.42M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -29.34MAU$ -32.72MAU$ -26.30M
Total LiabilitiesAU$ 1.00MAU$ 658.61KAU$ 2.02M
Stockholders EquityAU$ 28.48MAU$ 32.08MAU$ 24.40M
Cash Flow-
Free Cash Flow---
Operating Cash Flow---
Investing Cash Flow---
Financing Cash Flow---
Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

Invex Therapeutics Ltd. Debt to Assets

Invex Therapeutics Ltd. Cash Flow

Invex Therapeutics Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis